Low Dose Naltrexone for Pain in Patients With HIV

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 28, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Human Immunodeficiency VirusChronic Neuropathic Pain
Interventions
DRUG

Low Dose Naltrexone

Participants will start with 3mg LDN orally administered daily for one week, with a planned increase to 4 mg/day beginning week two, if tolerated. They will be provided with a 4-week supply of study medication. The most common side effects are difficulty sleeping and vivid dreams, which are seen more frequently with nighttime dosing, so LDN will be given as a daytime dose.

Trial Locations (3)

30303

RECRUITING

Grady Memorial Hospital, Atlanta

30308

RECRUITING

Emory Midtown Hospital, Atlanta

30322

RECRUITING

Emory University Hospital, Atlanta

All Listed Sponsors
lead

Emory University

OTHER